Photodynamic therapy for esophageal carcinoma

European Surgery - Acta Chirurgica Austriaca

Volumn 43, Issue 6, 2011, Pages 355-365

  Lindenmann, J ^a   Maier, A ^a   Matzi, V ^a   Neuboeck, N ^a   Anegg, U ^a   Porubsky, Ch ^a   Sankin, O ^a   Fell, B ^a   Renner, H ^a   Swatek, P ^a   Smolle Juettner, F M ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Dysphagia; Esophageal cancer; Palliative therapy; Photodynamic therapy; Quality of life

Indexed keywords

AMINOLEVULINIC ACID; ANALGESIC AGENT; ANTIEMETIC AGENT; ANTIINFLAMMATORY AGENT; PHOTOFRIN; PHOTOSAN; PROTON PUMP INHIBITOR; TEMOPORFIN; TRIAMCINOLONE; UNCLASSIFIED DRUG;

ANOREXIA; ARTICLE; BRACHYRADIOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL EXAMINATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DYSPHAGIA; ENDOSCOPIC MUCOSAL RESECTION; EPIGASTRIC PAIN; ESOPHAGUS CARCINOMA; FEASIBILITY STUDY; GENERAL ANESTHESIA; HEART ATRIUM FIBRILLATION; HUMAN; ILLUMINATION; KIDNEY FUNCTION; LASER; LIVER FUNCTION; NAUSEA; NAUSEA AND VOMITING; ODYNOPHAGIA; OUTCOME ASSESSMENT; OXYGEN SUPPLY; PARENTERAL NUTRITION; PATIENT CARE; PATIENT EDUCATION; PATIENT INFORMATION; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PORPHYRIA; QUALITY OF LIFE; SAFETY; STENT; SWALLOWING; THORAX PAIN; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR CELL; TUMOR NECROSIS;

EID: 84855884283     PISSN: 16828631     EISSN: 16824016     Source Type: Journal    
DOI: 10.1007/s10353-011-0051-x     Document Type: Article

References (88)

1. Dougherty TJ. Activated dyes as antitumor agents. J Natl Cancer Inst 1974;52:1333-6.
2. Barr H, Dix AJ, Kendall C, Stone N. The potential for photodynamic therapy in the Management of upper gastrointestinal disease. Alimentary Pharmacology & Therapeutics 2001;15: 311-21. (Pubitemid 32187553)
3. Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boule DG, Mitleman A. Photoradiation for the treatment of malignant tumors. Cancer Research 1978;38:2628-35.
4. Earlam R, Culina-Melo JR. Esophageal squamous cell carcinoma II. A critical review of radiotherapy. Br J Surg 1980;67:457-61. (Pubitemid 10080131)
5. Sabanathan S, Shah R, Mearns A, Richardson J, Goulden C, Shakir T. Results of surgical treatment of esophageal cancer. J.R. Coll Surg Edinb 1996;41:295-301. (Pubitemid 26340986)
6. McCaughan JS Jr, Hicks W, Laufman L, May E, Roach R. Palliation of esophageal malignancy with photo radiation therapy. Cancer 1984;54:2905-10. (Pubitemid 15184069)
7. Hayata Y, Kato M, Okitsu M. Photodynamic therapy with haematoporphyrin derivatives in cancer of the upper gastrointestinal tract. Sem Surg Oncol 1985;I:1-11. (Pubitemid 15007625)
8. Sibille A, Lambert R, Souquet JC, Sabben G, Decos F. Long term survival after photodynamic therapy for esophageal cancer. Gastro Enterology 1995;1008:3378-84.
9. Overhold BF, Panjenpour M, Haydek JM. Photodynamic therapy for ablation of dysphasia, reduction of specialized mucosa and treatment of superficial esophageal cancer. Gastro Intestinal Endoscopy 1995;42:64-70.
10. Overhold BF, Panjenpour M, Haydek JM. Photodynamic therapy of Barrett's oesophagus follow up in 100 patients. Gastrointestinal Endoscopy 1999;49:1-7. (Pubitemid 29076815)
11. Radu A, Wagniere C, Van den Berg H, Monnier P. Photodynamic therapy of early squamous cell cancer of the oesophagus. Gastrointestinal Endoscopy Clinics of North America 2000;10: 439-60. (Pubitemid 30429685)
12. Barr H, Shepard NA, Dix A, Roberts DJH, Tan WC, Krasner N. Eradication of high grade dysplasia in columnar lined (Barrett's oesophagus using photodynamic therapy with endogeneously generated protoporhyrin IX. Lancet 1996;348:584-5.
13. Ackroyd R, Brown NJ, Davis MF, et al. Photodynamic therapy for dysplastic Barrett's oesophagus: A prospective double blind randomized placebo controlled trial. Gut 2000;47:612-7.
14. Lewis I. The surgical treatment of carcinoma of the oesophagus with special reference to a new operation for growth of the middle third. Br J Surg 1946;34:18-31.
15. Li Y, Yang H, Cao J. Association between alcohol consumption and cancers in the Chinese population - a systematic review and meta-analysis. PLoS One 2011;6(4):e18776. Review.
16. Ellis FH Jr, Watkins E Jr, Krasna MG. Staging of carcinoma of the esophagus and cardia: a comparison of different staging criteria. Journal of Surgical Oncology 1993;52:231-5. (Pubitemid 23121937)
17. Moghissi K. Surgical resection for stage I cancer of the oesophagus and cardia. Br J Surg 1992;79:935-7.
18. DeMeester T, Stein HJ. Surgical therapy for cancer of the esophagus and cardia. In: Castell DO editors. The Esophagus, Boston: Little, Brown; 1992. pp. 299-41.
19. Nabeya K, Hanaoka T, Li S, Myumura T. What is ideal treatment for early esophageal cancer? Endoscopy 1993;25:670-1. (Pubitemid 24002754)
20. Sugimachi K, Ikebe M, Kitamura K. Long term results of esophagectomy for early esophageal carcinoma. Hepatogastroenterology 1993;40:203-6. (Pubitemid 23212165)
21. Oliver SE, Robertson CS, Logan RFA. Esophageal cancer: a opulation-based study of survival after treatment. Br J Surg 1992;79:1321-5. (Pubitemid 23008392)
22. Fok M, Sham JS, Chay D, Chung SWK, Wong J. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 1993;113:138-47. (Pubitemid 23060521)
23. Sur RK, Singh DP, Sharma SC. Radiation therapy of esophageal cancer: role of high dose rate brachytherapy. Int J Radiat Concol Biol Phys 1992;22:1043-6.
24. Sakamoto T, Kotah H, Shimizu T. Clinical results of treatment of advanced esophageal carcinoma with hyperthermia in combination with chemotherapy. Chest 1997;112:1487-93. (Pubitemid 28007752)
25. Rutgeerts P, Vantrappen G, Broeckaert L. Palliative Nd: YAG laser therapy for cancer of the esophagus and gastrooesopha-geal junction: impact on the quality of remaining life. Gastro-intest. Endosc 1988;34:87-90.
26. Maier A, Pinter H, Friehs GB, Renner H, Smolle-Juettner FM. Self-expandable coated stent after intraluminal treatment of esophageal cancer: a risky procedure? Ann Thorac Surg 1999; 67:781-4. (Pubitemid 29204745)
27. McCaughan JS Jr. Photodynamic therapy versus Nd: YAG laser treatment of endobronchial or esophageal malignancies. In: Spinelli P, Dal Fante M, Marchesini R, editors. Photodynamic therapy and biomedical lasers. New York: Elsevier; 1992. pp. 23-36.
28. Dougherty TJ, Marcus SL. Photodynamic therapy. Eur J Cancer 1992;28A:1734-42.
29. Pass HI. Photodynmic therapy in oncology: Mechanisms and clinical use. J Natl Cancer Inst 1993;85:443-56. (Pubitemid 23084089)
30. Grosjean P, Wagnieres G, Fontolliet C. Clinical photodynamic therapy for superficial cancer in the esophagus and the bronchi: 514nm compared with 630 nm light irradiation after sensitization with Photofrin II. Br J Cancer 1998;77:1989-95. (Pubitemid 28254645)
31. Lightdale CJ. Role of photodynamic therapy in the management of advanced esophageal cancer. Gastrointest Endosc Clin North America 2000;10:397-408. (Pubitemid 30429682)
32. Savary JF, Grosjean P, Monnier P. Photodynamic therapy for early squamous cell carcinomas of the esophagus: a review of 31 cases. Endoscopy 1998;30:258-65. (Pubitemid 28223111)
33. Grosjean P, Savary JF, Wagnieres G. Tetra(m-hydroxyphenyl)-chlorin clinical photodynamic therapy of early bronchial and oesophageal cancers. Lasers Med Sci 1996;11:227-35. (Pubitemid 27033056)
34. Hinnen P, deRooij FW, van Velthuysen ML. Biochemical basis of 5-aminolaevulinic acid induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus. Br J Cancer 1998;78:679-82. (Pubitemid 28375603)
35. Maier A, Tomaselli F, Matzi V, Rehak P, Pinter H, Smolle-Juettner FM. Photosensitization with hematoporphyrin derivative are more effective compared to 5-aminolaevulinic acid for photodynamic therapy of advanced esophageal carcinoma. AnnThoracSurg 2001;72:1136-40. (Pubitemid 32937991)
36. Maier A, Tomaselli F, Matzi V, Rehak P, Pinter H, Smolle-Juettner FM. Does new photosensitizer improve photodynamic therapy in advanced esophageal carcinoma? Lasers in Surgery and Medicine 2001;29(4):323-7. (Pubitemid 33022071)
37. Loh CS, Vernon D, MacRobert AJ. Endogeneous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. J Photochem Photobiol 1993;20:47-54. (Pubitemid 23257593)
38. Webber J, Kessel D, Fromm D. Side effects and photosensitization of human tissues after aminolaevulinic acid. J Surg Res 1997;68:31-7. (Pubitemid 27187996)
39. Heier SK, Rothmann K, Heier LM, Rosenthal WS. Randomized trial and light dosimetry of palliative photodynamic therapy (abstract). Gastrointest Endosc 1992;38:279.
40. Maier A, Anegg U, Fell B, et al. Effect of photodynamic therapy in a multimodal approach for advanced carcinoma of the gastro-esophageal junction. Lasers Surg Med 2000;26:461-6. (Pubitemid 30436648)
41. Maier A, Tomaselli F, Gebhard F, Rehak P, Smolle J, Smolle-Juettner FM. Palliation of advanced esophageal carcinoma by photodynamic therapy and irradiation. Ann Thorac Surg 2000; 69:1006-9. (Pubitemid 30259437)
42. Thomas RJ, Abott M, Bhathal PS, St John DJB, Morstyn G. High dose photoirradiation of esophageal cancer. Ann Surg 1987;206: 193-9. (Pubitemid 17104963)
43. Fingar VH, Henderson BW. Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response. Photochem Photobiol 1987;46:837-41.
44. Bown SG, Tralu CJ, Coleridge-Smith PD, Akdemir D, Wieman TJ. Photodynamic therapy with porphyrin and phtalocyanine senstization: quantitative studies in normal rat liver. Br J Cancer 1986;54:43-52. (Pubitemid 16093183)
45. Karanov S, Shopova M, Getov H. Photodynamic therapy in gastrointestinal cancers. Laser Surg Med 1991;11:395-8.
46. Song SZ, Li JH, Zou J, et al. Hematoporphyrin derivative and laser photodynamic reaction in the diagnosis and treatment of malignant tumors. Laser Surg Med 1985;5:61-6. (Pubitemid 15130030)
47. Gossner L, Wittke H, Warzecha A, et al. Dose-dependent destruction of human gastrointestinal neoplasms by photodynamic therapy: a quantitative pilot study in athymic nude mice. Eur J Gastroenterol Hepatol 1994;6:159-65. (Pubitemid 24053390)
48. Barr H, Krasner N, Boulus PB, Chatlani P, Bown SG. Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br J Surg 1990;77:93-6. (Pubitemid 20039090)
49. Kato H, Kawaguchi M, Konaka C, Hayata Y, Okitsu H. Evaluation of photodynamic therapy in gastric cancer. Laser Med Sci 1986; 1:67-74. (Pubitemid 17145871)
50. Cheong WF, Prahl SA, Welch AJ. A review of the optical properties of biological tussues. IEEE J Quant Elect 1990;26:2166-85.
51. Wilson BC, Patterson MS. The physics of photodynamic therapy. Phys Med Biol 1986;31:327-60. (Pubitemid 16069027)
52. Maier A, Sullmann D, Anegg U, et al. In vivo determination of tumor optical parameters in esophageal carcinoma. Lasers Surg Med 2000;27:350-7.
53. Gossner L, May A, Sroka R. A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia. Endoscopy 1999;31:370-6. (Pubitemid 29319805)
54. Wang KK. Current status of photodynamic therapy of Barrett's esophagus. Gastrointest Endosc 1999;49:S20-3. (Pubitemid 29129861)
55. van den Bergh H. On the evolution of some endoscopic light delivery systems for photodynamic therapy. Endoscopy 1998; 30:392-407. (Pubitemid 28353593)
56. Moghissi K, Dixon K, Thorpe JAC, Stringer M, Moore PJ. The role of photodynamic therapy (PDT) in inoperable oesophageal cancer. Eur J Card Thorac Surg 2000;17:95-100. (Pubitemid 30145579)
57. Moan J, Sommer S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res 1985;45(4):1608-10. (Pubitemid 15079112)
58. Tromberg BJ, Orenstein A, Kimel S. In vivo tumor oxygen tension measurements fort the evaluation of the efficiency of photodynamic therapy. Photochem Photobiol 1990;52(2):375-85.
59. Chen Q, Chen H, Shapiro H, Hetzel FW. Sequencing of combined hyperthermia and photodynamic therapy. Radiat Res 1996;146(3):293-7. (Pubitemid 26320093)
60. See K, Forbes I, Bets W. Oxygen dependency of phototoxicity with hematoporphyrin derivative. Photochem Photobiol 1986; 44:711-6.
61. Gomer C, Razum N. Acute skin response in albino mice following porphyrin photosensitization under oxic and anoxic conditions. Photochem Photobiol 1984;40:435-9.
62. Gibson SL, Hilf RC. Interdependence of fluence, drug dose and oxygen on hematoporphyrin derivative induced photosensitization of tumor mitochondria. Photochem Photobiol 1985; 42:367-73.
63. Foote CS. Mechanisms of photooxygenation. In: Doiron DR, Gomer CJ, editors. Porphyrin localization and treatment of tumors. New York: Alan R. Liss; 1984. p. 3.
64. Athar M, Elmets CA, Bickers DR. A novel mechanism for the generation of superoxide anions in hematoporphyrin derivative mediated cutaneous photosensitization. Activation of the xanthine oxidase pathway. J Clin Invest 1989;83:1137-43. (Pubitemid 19113024)
65. Moan J, Peng Q, Sorensen R, Iani V, Nesland JM. The biophysical foundations of photodynamic therapy. Endoscopy 1998;30: 387-91. (Pubitemid 28353592)
66. McCaughan JS, Williams TE, Bethel BH. Palliation of esophageal malignancy with photodynamic therapy. Ann Thorac Surg 1985; 40(2):113-20. (Pubitemid 15246580)
67. Moghissi K, Dixon K. Photodynamic therapy (PDT) in esophageal cancer: a surgical view of its indications based on 14 years experience. Technology in Cancer Research and Treatment 2003;2(4):319-26. (Pubitemid 37022348)
68. Maier A, Tomaselli F, Anegg U, et al. Combined photodynamic therapy and hyperbaric oxygenation in carcinoma of the esophagus and the esophago-gastric junction. Eur J Card Thorac Surg 2000;18:649-55.
69. Jirsa M Jr, Pouchiva P, Dolezal J, Pospisil J, Jirsa M. Hyperbaric oxygen and photodynamic therapy in tumor-bearing nude mice. Eur J Cancer 1991;27(1):109.
70. Dong GC, Hu SX, Zhao GY, Gao SZ, Wu LR. Experimental study on cytotoxic effects of hyperbaric oxygen and photodynamic therapy on mouse transplanted tumor. Chin Med J Engl 1987; 100(9):697-702.
71. Messmann H, Szeimies RM, Bäumler W, et al. Enhanced effectiveness of photodynamic therapy with laser light fractionation in patients with esophageal cancer. Endoscopy 1997;29:275-80. (Pubitemid 27322931)
72. Buttar NS, Wang KK, Lutzke LS, Krishnadath KK, Anderson MA. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc 2001;54:682-8. (Pubitemid 33668674)
73. Kubba AK. Role of photodynamic therapy in the management of gastrointestinal cancer. Digestion 1999;60:1-10. (Pubitemid 29042085)
74. Luketich JD, Christie NA, Buenaventura PO, Weigel TL, Keenan RJ, Nguyen NT. Endoscopic phtotodynamic therapy for obstructing esophageal cancer: 77 cases over a 2-year period. Surg Endosc 2000;14:653-7. (Pubitemid 30626218)
75. McCaughan JS Jr, Ellison EC, Guy JT, et al. Photodynamic therapy for esopahgeal malignancy: a prospective twelve-year study. Ann Thorac Surg 1996;62:1005-10. (Pubitemid 26340312)
76. Mall JW, Zuckermann-Becker H, Pollmann C, Opitz I, Rogalla, P, Walter M. Esophageal necrosis and perforation of the left main bronchus following photodynamic therapy of esophageal carcinoma. Thorac Cardiovasc Surg 2002;50:111-3. (Pubitemid 34547171)
77. Tomaselli F, Maier A, Sankin O, Woltsche M, Pinter H, Smolle-Jüttner FM. Successful endoscopical sealing of malignant esophagotracheal fistulae by using a covered self-expandable stenting system. Eur J Cardthor Surg 2001;20:734-8. (Pubitemid 33713617)
78. Panjehpour M, Overhold BF, Haydek JM. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barretts esophagus and effects of oral steroids on stricture formation. Am J Gastroenterol 2000;95:2177-84.
79. Stepanic T, Grosjean P, Woodtli A. Optimization of the diameter of a radial irradiation device for photodynamic therapy in the esophagus. Endoscopy 2002;34:411-5. (Pubitemid 34464203)
80. Overholt BF, Panjehpour M. Photodynamic therapy for Barrett's esohagus. Gastrointest Endosc Clin N Am 1997;7:207-20.
81. Lightdale CJ, Heier SK, Marcon NE. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd: YAG laser for palliation of oesophageal cancer: a multicenter randomized trial. Gastrointest. Endosc 1995;42:507-12.
82. Savary JF, Monnier P, Fontolliet C. Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra(hydroxyphenyl)chlorine. Arch Otolaryngol Head and Neck Surg 1997;123:162-8. (Pubitemid 27076511)
83. Patrice T, Foultier MT, Yactayo S. Endoscopic photodynamic therapy with hematoporphyrin derivative for primary treatment of gastrointestinal neoplasms in inoperable patients. Dig Dis Sci 1990;35:545-52. (Pubitemid 20172957)
84. Calzavara F, Tomio L, Corti L. Oesophageal cancer treated by photodynamic therapy alone or followed by radiation therapy. J Photochem Photobiol 1990;6:176-4.
85. Inoue H. Endoscopic mucosal resection for esophageal and gastric mucosal cancers. Can J Gastroenterol 1998;12:355-9. (Pubitemid 28403440)
86. Soehendra N, Binmoeller KF, Bohnacker S, et al. Endoscopic snare mucosectomy in the esophagus without any additional equipment: a simple technique for resection of flat early cancer. Endoscopy 1997;29:380-3. (Pubitemid 27370857)
87. Ell C, May A, Gossner L. Pech O, Gunter E, Mayer G. Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett's esophagus. Gastroenterology 2000;118:670-7. (Pubitemid 30171616)
88. May A, Gossner L, Pech O. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2002;14: 1085-91. (Pubitemid 35178769)